Mitochondrial metabolism and type-2 diabetes: a specific target of metformin (Q35539967)

8 August 2017

1 reference

title

Mitochondrial metabolism and type-2 diabetes: a specific target of metformin (English)

1 reference

8 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(03)72792-X

12 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(03)72792-X

12 March 2024

5

E. A. Koceir

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502105

12 March 2024

author name string

X. M. Leverve

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502105

12 March 2024

B. Guigas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502105

12 March 2024

D. Detaille

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502105

12 March 2024

C. Batandier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502105

12 March 2024

C. Chauvin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502105

12 March 2024

E. Fontaine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502105

12 March 2024

N. F. Wiernsperger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502105

12 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14502105

12 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S126236360372792X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(03)72792-X

https://api.elsevier.com/content/article/PII:S126236360372792X?httpAccept=text/plain

12 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(03)72792-X

12 March 2024

published in

Diabetes and Metabolism

1 reference

8 August 2017

29

1 reference

8 August 2017

6S88-94

1 reference

8 August 2017

4 Pt 2

1 reference

The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

The double puzzle of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

1 reference

7 January 2021

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

1 reference

7 January 2021

Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Mechanism by which metformin reduces glucose production in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Metformin improves liver antioxidant potential in rats fed a high-fructose diet

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Effect of metformin on glutathione and magnesium in normal and streptozotocin-induced diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Influence of atenolol and/or metformin on glutathione and magnesium levels in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Cellular mechanism of action of metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Gluconeogenesis and related aspects of glycolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

A proposal for the locus of metformin's clinical action: potentiation of the activation of pyruvate kinase by fructose-1,6-diphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

The missing link: a single unifying mechanism for diabetic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Hyperglycemia and oxidative stress: complex relationships with attractive prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

A mitochondrial perspective on cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Mitochondria and cell death. Mechanistic aspects and methodological issues

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Progress on the mitochondrial permeability transition pore: regulation by complex I and ubiquinone analogs.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation By electron flow through the respiratory chain complex i.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

The effects of glucose, insulin and metformin on the order parameters of isolated red cell membranes. An electron paramagnetic resonance spectroscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Action of metformin on erythrocyte membrane fluidity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Erythrocyte insulin receptor tyrosine kinase activity is increased in glyburide-treated patients with type 2 diabetes in good glycaemic control.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Site-specific uncoupling and inhibition of oxidative phosphorylation by biguanides. II

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Interaction of biguanides with mitochondrial and synthetic membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

The effects of metformin compared to the effects of phenformin on the lactate production and the metabolism of isolated parenchymal rat liver cell

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Characterization of stages in development of obesity-diabetes syndrome in sand rat (Psammomys obesus)

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Psammomys obesus of the Jerusalem colony: a model for nutritionally induced, non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Albert Renold memorial lecture: molecular background of nutritionally induced insulin resistance leading to type 2 diabetes--from animal models to humans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Low rate of glucose 6-phosphate hydrolysis in liver cells is a physiological feature of non-diabetic wild sand rats (Psammomys obesus).

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972792-X

7 January 2021

AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes

28

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(03)72792-X

Biguanides. A review of history, pharmacodynamics and therapy

12 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(03)72792-X

12 March 2024

Identifiers

0 references

1 reference